Shares of Dr Reddy's Laboratories today fell by over 2 per cent after the company posted a 38.51 per cent decline in consolidated net profit for the third quarter ended December 31.
The stock dipped 2.26 per cent to end at Rs 2,504 on BSE. During the day, it lost 4 per cent to Rs 2,458.95.
At NSE, shares of the company fell 2 per cent to close at Rs 2,507.75.
Dr Reddy's Laboratories today posted a 38.51 per cent decline in consolidated net profit at Rs 302.7 crore for the third quarter ended December 31.
The company had posted a net profit of Rs 492.3 crore during the same period of previous fiscal.
Its total revenue from operations stood at Rs 3,834.1 crore for the quarter under review. It was Rs 3,723.2 crore during the third quarter of 2016-17, Dr Reddy's Labs said in a regulatory filing.
The company said total revenue from operations for the quarter was not comparable consequent to introduction of Goods and Services Tax on July 1.
Disclaimer: No Business Standard Journalist was involved in creation of this content
